Orchestra BioMed holds two best-in-class medical device therapies targeting large markets, with strong partnerships and equity investments from Medtronic and Terumo. Both AVIM Therapy and Virtue SAB ...

Ultra-low-power analog signal processing circuits are essential for energy-constrained biomedical systems. This paper presents a novel gate-driven multiple-input operational transconductance amplifier ...

Bio-Med Devices Inc. has been shaping the future of respiratory care for over 50 years, but its story is more than a timeline – it’s a legacy built on family, risk and deep-rooted purpose. The company ...

Surmodics has acquired the business of Alta Biomed, expanding its portfolio of hemocompatible and biocompatible surface ...

With biomedical, IoT, and imaging systems becoming networked endpoints, many health systems lack the staffing models, inventory visibility, and governance needed to manage risk and maintain clinical ...

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...

Incomplete device visibility and inventory: Many healthcare organizations still rely on manual spreadsheets, disconnected systems, or point tools to track biomedical and IoT devices, making it ...